Mirati Therapeutics Files Patent for Substituted Quinoxalines
Summary
The European Patent Office has published patent application EP4709714A1 filed by Mirati Therapeutics, Inc. for substituted quinoxalines. This publication relates to potential new therapeutic compounds.
What changed
The European Patent Office (EPO) has published patent application EP4709714A1, filed by Mirati Therapeutics, Inc., concerning substituted quinoxalines. The application, published on March 18, 2026, includes inventors from Mirati Therapeutics and lists various IPC classifications related to organic chemistry and therapeutic applications, specifically A61P 35/00 (antineoplastic agents).
This publication represents the granting of a patent application, not a new regulatory requirement for other entities. For Mirati Therapeutics, this signifies progress in their intellectual property portfolio for potential drug candidates. Compliance officers should note this as an indicator of R&D activity in the oncology space but no immediate compliance actions are required for other regulated entities.
Source document (simplified)
SUBSTITUTED QUINOXALINES
Publication EP4709714A1 Kind: A1 Mar 18, 2026
Applicants
Mirati Therapeutics, Inc.
Inventors
MARX, Matthew, Arnold, SMITH, Christopher, Ronald, KETCHAM, John, Michael, HARWOOD, Stephen, BURNS, Aaron, Craig, LAWSON, John, David, CADDELL-HAATVEIT, Kersti
IPC Classifications
C07D 241/44 20060101AFI20241122BHEP C07D 401/04 20060101ALI20241122BHEP C07D 401/12 20060101ALI20241122BHEP C07D 401/14 20060101ALI20241122BHEP C07D 403/04 20060101ALI20241122BHEP C07D 417/12 20060101ALI20241122BHEP C07D 491/18 20060101ALI20241122BHEP C07D 491/20 20060101ALI20241122BHEP C07D 498/20 20060101ALI20241122BHEP A61P 35/00 20060101ALI20241122BHEP A61K 31/498 20060101ALI20241122BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Therapeutics (A61P) publishes new changes.